|
1
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu
Y, Gong Z, Zhang S, Zhou J, Cao K, et al: Role of tumor
microenvironment in tumorigenesis. J Cancer. 8:761–773. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Polyak K, Haviv I and Campbell IG:
Co-evolution of tumor cells and their microenvironment. Trends
Genet. 25:30–38. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shiga K, Hara M, Nagasaki T, Sato T,
Takahashi H and Takeyama H: Cancer-associated fibroblasts: their
characteristics and their roles in tumor growth. Cancers (Basel).
7:2443–2458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Orimo A and Weinberg RA: Heterogeneity of
stromal fibroblasts in tumors. Cancer Biol Ther. 6:618–619. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eyden B: The myofibroblast: Phenotypic
characterization as a prerequisite to understanding its functions
in translational medicine. J Cell Mol Med. 12:22–37. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gabbiani G: The biology of the
myofibroblast. Kidney Int. 41:530–532. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hinz B, Phan SH, Thannickal VJ, Prunotto
M, Desmoulière A, Varga J, De Wever O, Mareel M and Gabbiani G:
Recent developments in myofibroblast biology: Paradigms for
connective tissue remodeling. Am J Pathol. 180:1340–1355. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hinz B, Phan SH, Thannickal VJ, Galli A,
Bochaton-Piallat ML and Gabbiani G: The myofibroblast: One
function, multiple origins. Am J Pathol. 170:1807–1816. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Desmoulière A, Guyot C and Gabbiani G: The
stroma reaction myofibroblast: A key player in the control of tumor
cell behavior. Int J Dev Biol. 48:509–517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pietras K and Ostman A: Hallmarks of
cancer: Interactions with the tumor stroma. Exp Cell Res.
316:1324–1331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grugan KD, Miller CG, Yao Y, Michaylira
CZ, Ohashi S, Klein-Szanto AJ, Diehl JA, Herlyn M, Han M, Nakagawa
H, et al: Fibroblast-secreted hepatocyte growth factor plays a
functional role in esophageal squamous cell carcinoma invasion.
Proc Natl Acad Sci USA. 107:11026–11031. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Couto N, Caja S, Maia J, Strano Moraes MC
and Costa-Silva B: Exosomes as emerging players in cancer biology.
Biochimie. S0300-9084(18)30067-1. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De Wever O, Demetter P, Mareel M and
Bracke M: Stromal myofibroblasts are drivers of invasive cancer
growth. Int J Cancer. 123:2229–2238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
Outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
|
17
|
Shay G, Lynch CC and Fingleton B: Moving
targets: Emerging roles for MMPs in cancer progression and
metastasis. Matrix Biol. 44-46:200–206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mehner C and Radisky DC: Triggering the
landslide: The tumor-promotional effects of myofibroblasts. Exp
Cell Res. 319:1657–1662. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gargus M, Niu C, Vallone JG, Binkley J,
Rubin DC and Shaker A: Human esophageal myofibroblasts secrete
proinflammatory cytokines in response to acid and Toll-like
receptor 4 ligands. Am J Physiol Gastrointest Liver Physiol.
308:G904–G923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Czepán M, Rakonczay Z Jr, Varró A, Steele
I, Dimaline R, Lertkowit N, Lonovics J, Schnúr A, Biczó G, Geisz A,
et al: NHE1 activity contributes to migration and is necessary for
proliferation of human gastric myofibroblasts. Pflugers Arch.
463:459–475. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bensadoun A and Weinstein D: Assay of
proteins in the presence of interfering materials. Anal Biochem.
70:241–250. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiao Y, Feng X, Zhan Y, Wang R, Zheng S,
Liu W and Zeng X: Matrix metalloproteinase-2 promotes αvβ3
integrin-mediated adhesion and migration of human melanoma cells by
cleaving fibronectin. PLoS One. 7:e415912012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu CF, Chen FH, Lu MH, Hong JH and Chiang
CS: Dual roles of tumour cells-derived matrix metalloproteinase 2
on brain tumour growth and invasion. Br J Cancer. 117:1828–1836.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yazdani S, Bansal R and Prakash J: Drug
targeting to myofibroblasts: Implications for fibrosis and cancer.
Adv Drug Deliv Rev. 121:101–116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Holmberg C, Ghesquière B, Impens F,
Gevaert K, Kumar JD, Cash N, Kandola S, Hegyi P, Wang TC, Dockray
GJ, et al: Mapping proteolytic processing in the secretome of
gastric cancer-associated myofibroblasts reveals activation of
MMP-1, MMP-2, and MMP-3. J Proteome Res. 12:3413–3422. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang L, Gonda TA, Gamble MV, Salas M,
Seshan V, Tu S, Twaddell WS, Hegyi P, Lazar G, Steele I, et al:
Global hypomethylation of genomic DNA in cancer-associated
myofibroblasts. Cancer Res. 68:9900–9908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baxter E, Windloch K, Gannon F and Lee JS:
Epigenetic regulation in cancer progression. Cell Biosci. 4:452014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang G and Pradhan S: Mammalian
epigenetic mechanisms. IUBMB Life. 66:240–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Albrengues J, Bertero T, Grasset E, Bonan
S, Maiel M, Bourget I, Philippe C, Herraiz Serrano C, Benamar S,
Croce O, et al: Epigenetic switch drives the conversion of
fibroblasts into proinvasive cancer-associated fibroblasts. Nat
Commun. 6:102042015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Andrade VP, Morrogh M, Qin LX, Olvera N,
Giri D, Muhsen S, Sakr RA, Schizas M, Ng CK, Arroyo CD, et al: Gene
expression profiling of lobular carcinoma in situ reveals candidate
precursor genes for invasion. Mol Oncol. 9:772–782. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Y, Wang X, Wu F, Huang R, Xue F, Liang
G, Tao M, Cai P and Huang Y: Transcriptome profiling of the cancer,
adjacent non-tumor and distant normal tissues from a colorectal
cancer patient by deep sequencing. PLoS One. 7:e410012012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Coskunpinar E, Oltulu YM, Orhan KS,
Tiryakioglu NO, Kanliada D and Akbas F: Identification of a
differential expression signature associated with tumorigenesis and
metastasis of laryngeal carcinoma. Gene. 534:183–188. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Berdiel-Acer M, Sanz-Pamplona R, Calon A,
Cuadras D, Berenguer A, Sanjuan X, Paules MJ, Salazar R, Moreno V,
Batlle E, et al: Differences between CAFs and their paired NCF from
adjacent colonic mucosa reveal functional heterogeneity of CAFs,
providing prognostic information. Mol Oncol. 8:1290–1305. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Navab R, Strumpf D, Bandarchi B, Zhu CQ,
Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L,
Barczyk M, et al: Prognostic gene-expression signature of
carcinoma-associated fibroblasts in non-small cell lung cancer.
Proc Natl Acad Sci USA. 108:7160–7165. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pestell TG, Jiao X, Kumar M, Peck AR,
Prisco M, Deng S, Li Z, Ertel A, Casimiro MC, Ju X, et al: Stromal
cyclin D1 promotes heterotypic immune signaling and breast cancer
growth. Oncotarget. 8:81754–81775. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu J, Long Z, Cai H, Du C, Liu X, Yu S and
Wang Y: High expression of WISP1 in colon cancer is associated with
apoptosis, invasion and poor prognosis. Oncotarget. 7:49834–49847.
2016.PubMed/NCBI
|
|
39
|
Desnoyers L, Arnott D and Pennica D:
WISP-1 binds to decorin and biglycan. J Biol Chem. 276:47599–47607.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Su F, Overholtzer M, Besser D and Levine
AJ: WISP-1 attenuates p53-mediated apoptosis in response to DNA
damage through activation of the Akt kinase. Genes Dev. 16:46–57.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sreedhar A, Petruska P, Miriyala S,
Panchatcharam M and Zhao Y: UCP2 overexpression enhanced glycolysis
via activation of PFKFB2 during skin cell transformation.
Oncotarget. 8:95504–95515. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Orr B, Vanpoucke G, Grace OC, Smith L,
Anderson RA, Riddick AC, Franco OE, Hayward SW and Thomson AA:
Expression of pleiotrophin in the prostate is androgen regulated
and it functions as an autocrine regulator of mesenchyme and cancer
associated fibroblasts and as a paracrine regulator of epithelia.
Prostate. 71:305–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Costanza B, Umelo IA, Bellier J,
Castronovo V and Turtoi A: Stromal Modulators of TGF-β in cancer. J
Clin Med. 6:62017. View Article : Google Scholar :
|
|
44
|
Tian M, Neil JR and Schiemann WP:
Transforming growth factor-β and the hallmarks of cancer. Cell
Signal. 23:951–962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Miyamoto Y, Hanna DL, Zhang W, Baba H and
Lenz HJ: Molecular pathways: Cachexia signaling - a targeted
approach to cancer treatment. Clin Cancer Res. 22:3999–4004. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wallner C, Drysch M, Becerikli M, Jaurich
H, Wagner JM, Dittfeld S, Nagler J, Harati K, Dadras M, Philippou
S, et al: Interaction with the GDF8/11 pathway reveals treatment
options for adenocarcinoma of the breast. Breast. 37:134–141. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rosanò L and Bagnato A: Endothelin
therapeutics in cancer: Where are we? Am J Physiol Regul Integr
Comp Physiol. 310:R469–R475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bakrania BA, Spradley FT, Satchell SC,
Stec DE, Rimoldi JM, Gadepalli RSV and Granger JP: Heme oxygenase-1
is a potent inhibitor of placental ischemia-mediated endothelin-1
production in cultured human glomerular endothelial cells. Am J
Physiol Regul Integr Comp Physiol. 314:R427–R432. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Barajas-Castañeda LM, Cortés-Gutiérrez E,
García-Rodríguez FM, Campos-Rodríguez R, Lara-Padilla E,
Enríquez-Rincón F, Castro-Mussot ME and Figueroa-Arredondo P:
Overexpression of MMP-3 and uPA with diminished PAI-1 related to
metastasis in ductal breast cancer patients attending a public
hospital in Mexico City. J Immunol Res. 2016:85196482016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang W, Ding YQ, Li ZG, Han HX and Yang L:
Expression and diagnostic application of C4.4A protein in squamous
cell carcinoma and adenocarcinoma. Zhonghua Bing Li Xue Za Zhi.
35:277–280. 2006.(In Chinese). PubMed/NCBI
|
|
51
|
Yu PF, Huang Y, Xu CL, Lin LY, Han YY, Sun
WH, Hu GH, Rabson AB, Wang Y and Shi YF: Downregulation of CXCL12
in mesenchymal stromal cells by TGFβ promotes breast cancer
metastasis. Oncogene. 36:840–849. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hua H, Li M, Luo T, Yin Y and Jiang Y:
Matrix metalloproteinases in tumorigenesis: An evolving paradigm.
Cell Mol Life Sci. 68:3853–3868. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Koyama S: Coordinate cell-surface
expression of matrix metalloproteinases and their inhibitors on
cancer-associated myofibroblasts from malignant ascites in patients
with gastric carcinoma. J Cancer Res Clin Oncol. 131:809–814. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sameni M, Anbalagan A, Olive MB, Moin K,
Mattingly RR and Sloane BF: MAME models for 4D live-cell imaging of
tumor: Microenvironment interactions that impact malignant
progression. J Vis Exp. 60:36612012.
|
